Frequently Asked Questions about UnitedHealth Group Incorporated (UNH)

Name: UnitedHealth Group Incorporated (UNH) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does UnitedHealth Group Incorporated (UNH) do?

Accepted Answer

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national emp...

Question 2

Is UnitedHealth Group Incorporated (UNH) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of UNH reveals an Altman Z-Score of 2.71 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($447.57B most recent), help investors decide if UNH fits their risk profile.

Question 3

What is the current P/E ratio for UNH?

Accepted Answer

As of the latest trading session, UnitedHealth Group Incorporated (UNH) has a trailing P/E ratio of 21.24.

Question 4

Who is the CEO of UnitedHealth Group Incorporated?

Accepted Answer

The current Chief Executive Officer of UnitedHealth Group Incorporated is Stephen J. Hemsley.

Question 5

What was UNH's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, UnitedHealth Group Incorporated reported annual revenues of $447.57B (2025), $400.28B (2024), $371.62B (2023), $324.16B (2022), $287.60B (2021) respectively.

Question 6

Does UNH pay a dividend?

Accepted Answer

UnitedHealth Group Incorporated currently pays a dividend to its shareholders, with a trailing dividend yield of 3.14%.

Question 7

How much debt and cash flow does UNH have?

Accepted Answer

In its latest reporting period, UnitedHealth Group Incorporated generated $16.07B in Free Cash Flow against a total debt load of $78.39B.

Question 8

What is the Price-to-Book (P/B) ratio of UnitedHealth Group Incorporated?

Accepted Answer

The Price-to-Book (P/B) ratio for UnitedHealth Group Incorporated (UNH) is currently 2.72.

Question 9

What is the Price-to-Sales (P/S) ratio of UNH?

Accepted Answer

Based on trailing twelve-month data, UnitedHealth Group Incorporated (UNH) trades at a Price-to-Sales (P/S) ratio of 0.57.

Question 10

What is UnitedHealth Group Incorporated's Return on Equity (ROE)?

Accepted Answer

UnitedHealth Group Incorporated (UNH) has a Return on Equity (ROE) of 12.70%, representing its profitability relative to shareholder equity.

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	447.6B	82.9B	19B	12.1B	13.23
2024-12	400.3B	89.4B	32.3B	14.4B	15.64
2023-12	371.6B	91B	32.4B	22.4B	24.12
2022-12	324.2B	79.6B	28.4B	20.1B	21.54
2021-12	287.6B	69.7B	24B	17.3B	18.33

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	447.6B	82.9B	19B	12.1B	13.23
2024-12	400.3B	89.4B	32.3B	14.4B	15.64
2023-12	371.6B	91B	32.4B	22.4B	24.12
2022-12	324.2B	79.6B	28.4B	20.1B	21.54
2021-12	287.6B	69.7B	24B	17.3B	18.33